References
- Bax R. P., Young J. P. W. Cefotaxime: United Kingdom clinical trial results in the treatment of severe infections. Curr. Med. Res. Opin. 1981; 7: 4011. Bax R. P., Young J. P. W. Cefotaxime: United Kingdom clinical trial results in the treatment of severe infections. Curr. Med. Res. Opin. 1981; 7: 401
- Belohradsky B. H., Geiss D., Marget W., Bruch K., Kafetzis D., Peters G. Intravenous cefotaxime in children with bacterial meningitis. Lancet 1980; 1: 612. Belohradsky B. H., Geiss D., Marget W., Bruch K., Kafetzis D., Peters G. Intravenous cefotaxime in children with bacterial meningitis. Lancet 1980; 1: 61
- Brown W. M., Fallon R. J. Cefotaxime for bacterial meningitis. Lancet 1979; 1: 12463. Brown W. M., Fallon R. J. Cefotaxime for bacterial meningitis. Lancet 1979; 1: 1246
- Daikos G. K., Kosmidis J., Giamarellou H., Dravidis B., Stathakis C. L., Mantopoulos K. Evaluation of cefotaxime in a hospital with high antibiotic resistance rates. J. Antimicrob. Chemother. 1980; 6(Suppl. A)2554. Daikos G. K., Kosmidis J., Giamarellou H., Dravidis B., Stathakis C. L., Mantopoulos K. Evaluation of cefotaxime in a hospital with high antibiotic resistance rates. J. Antimicrob. Chemother. 1980; 6(Suppl. A)255
- Drasar F. A., Farrell W., Howard A. J., Hince C., Leung T., Williams J. D. Activity of HR756 against Haemophilus influenzae, Bacteroides fragilis and Gram-negative rods. J. Antimicrob. Chemother. 1978; 4: 4455. Drasar F. A., Farrell W., Howard A. J., Hince C., Leung T., Williams J. D. Activity of HR756 against Haemophilus influenzae, Bacteroides fragilis and Gram-negative rods. J. Antimicrob. Chemother. 1978; 4: 445
- Hamilton-Miller J. M. T., Brumfitt W., Reynolds A. V. Cefotaxime (HR 756) a new cephalosporin with exceptional broad spectrum activity, in vitro. J. Antimicrob. Chemother. 1978; 4: 4376. Hamilton-Miller J. M. T., Brumfitt W., Reynolds A. V. Cefotaxime (HR 756) a new cephalosporin with exceptional broad spectrum activity, in vitro. J. Antimicrob. Chemother. 1978; 4: 437
- McKendrick M. W., Geddes A. M., Wise R., Andrews J. A. Cefotaxime – a clinical study. J. Antimicrob. Chemother. 1981; 7: 4057. McKendrick M. W., Geddes A. M., Wise R., Andrews J. A. Cefotaxime – a clinical study. J. Antimicrob. Chemother. 1981; 7: 405
- Newsom S. W. B., Matthews J., Pearce V. R. Cefotaxime in urinary infections. J. Antimicrob. Chemother. 1980; 6(Suppl. A)1998. Newsom S. W. B., Matthews J., Pearce V. R. Cefotaxime in urinary infections. J. Antimicrob. Chemother. 1980; 6(Suppl. A)199
- Rimmer D. (1979) Cefotaxime in the treatment of septicaemia. Proc. 19th I.C.A.A.C., Boston, Oct., 1979, 1329. Rimmer D. (1979) Cefotaxime in the treatment of septicaemia. Proc. 19th I.C.A.A.C., Boston, Oct., 1979, 132
- Young J. P. W., Husson J. M., Bruch K., Blomer R. J., Savopoulos C. The evaluation of efficacy and safety of cefotaxime: a review of 2500 cases. J. Antimicrob. Chemother. 1980; 6(Suppl. A)29310. Young J. P. W., Husson J. M., Bruch K., Blomer R. J., Savopoulos C. The evaluation of efficacy and safety of cefotaxime: a review of 2500 cases. J. Antimicrob. Chemother. 1980; 6(Suppl. A)293